99-1522. FDA In Vitro Diagnostic Products; Public Workshop  

  • [Federal Register Volume 64, Number 15 (Monday, January 25, 1999)]
    [Notices]
    [Page 3703]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-1522]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    FDA In Vitro Diagnostic Products; Public Workshop
    
    AGENCY:  Food and Drug Administration, HHS.
    
    ACTION:  Notice.
    
    -----------------------------------------------------------------------
    
        The Food and Drug Administration (FDA), Los Angeles District 
    Office, in cooperation with the Orange County Regulatory Affairs 
    Discussion Group (OCRA) is announcing the following public workshop: 
    FDA In Vitro Diagnostic (IVD) Products. The workshop will address 
    issues related to the manufacture of IVD products by Southern 
    California and Arizona IVD manufacturers.
        Date and Time: The workshop will be held on Tuesday, February 2, 
    1999, 8:15 a.m. to 5:30 p.m.
        Location: The workshop will be held at the Food and Drug 
    Administration, Los Angeles District Office, 19900 MacArthur Blvd., 
    suite 300, Irvine, CA 92612.
        Contact: Michael O. Stokke, Supervisory Consumer Safety Officer, 
    Food and Drug Administration, 19900 MacArthur Blvd., suite 300, Irvine, 
    CA 92612, 949-798-7790, FAX 949-798-7771, e-mail 
    mstokke@ora.fda.gov'', or Ken Michael, OCRA Programs Chair, 619-487-
    5676, FAX 619-485-0829.
        Registration: Send registration information (including name, title, 
    firm name, address, telephone, fax number, and fee) to OCRA, FDA IVD 
    Products Workshop, 5405 Alton Pkwy., suite 5A-624, Irvine, CA 92604, by 
    Monday, January 25, 1999. There is a $100 registration fee payable to 
    OCRA (address above) for the workshop. The fee will cover actual 
    expenses including refreshments, materials, and speaker expenses. The 
    workshop will continue through lunch, which will be provided. Due to 
    space limitations, attendance is limited to 200 persons, and only 1 
    person per organization may attend. If space is still available, 
    additional persons from the same organization may be admitted.
        If you need special accommodations due to a disability, please 
    contact Michael O. Stokke at least 7 days in advance.
    
        Dated: January 15, 1999.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 99-1522 Filed 1-22-99; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
01/25/1999
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
99-1522
Pages:
3703-3703 (1 pages)
PDF File:
99-1522.pdf